Bank Of America Corp Gelesis Holdings, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.11 - $0.52 $1,223 - $5,783	11,123 Added 94.36%	22,911 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.22 - $0.51 $1,760 - $4,082	8,004 Added 211.52%	11,788 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $152 - $2,550	1,903 Added 101.17%	3,784 $4,000
Q2 2022 Aug 12, 2022	SELL	N/A	-2,144 Reduced 53.27%	1,881 $0
Q1 2022 May 16, 2022	BUY	N/A	4,025 New	4,025 $18,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.